Horien Biochemical Technology Co (ROCO:7814) Beneish M-Score: -0.83 (As of Jun. 28, 2026)


ROCO:7814 Horien Biochemical Technology Co Ltd ROCO:7814
21 GF Score
Price NT$38.65
! 5 Warning Signs
View Full Analysis

What is Horien Biochemical Technology Co Beneish M-Score?

Horien Biochemical Technology Co ROCO:7814 -6.53% 21 Beneish M-Score is -0.83 as of Jun. 28, 2026. GuruFocus rates ROCO:7814 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 829 Biotechnology companies, Horien Biochemical Technology Co ranks worse than 79.49% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.83 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Horien Biochemical Technology Co's Beneish M-Score or its related term are showing as below:

ROCO:7814' s Beneish M-Score Range Over the Past 10 Years
Min: -3.22   Med: -2.03   Max: -0.83
Current: -0.83

During the past 4 years, the highest Beneish M-Score of Horien Biochemical Technology Co was -0.83. The lowest was -3.22. And the median was -2.03.


Horien Biochemical Technology Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Horien Biochemical Technology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Horien Biochemical Technology Co Beneish M-Score Chart

Horien Biochemical Technology Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beneish M-Score
0.00 0.00 -3.22 -0.83

Horien Biochemical Technology Co Quarterly Data
Dec22 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial 0.00 -3.22 0.00 0.00 -0.83

ROCO:7814 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Horien Biochemical Technology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Horien Biochemical Technology Co Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Horien Biochemical Technology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Horien Biochemical Technology Co's Beneish M-Score falls into.


ROCO:7814
21GF Score
Horien Biochemical Technology Co Ltd ROCO:7814
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Horien Biochemical Technology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Horien Biochemical Technology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2005+0.528 * 1.0672+0.404 * 4.9462+0.892 * 0.8469+0.115 * 0.7778
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.3868+4.679 * 0.004946-0.327 * 0.8684
=-0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$16.61 Mil.
Revenue was NT$83.04 Mil.
Gross Profit was NT$58.55 Mil.
Total Current Assets was NT$249.99 Mil.
Total Assets was NT$320.25 Mil.
Property, Plant and Equipment(Net PPE) was NT$65.81 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$8.69 Mil.
Selling, General, & Admin. Expense(SGA) was NT$56.84 Mil.
Total Current Liabilities was NT$26.08 Mil.
Long-Term Debt & Capital Lease Obligation was NT$0.07 Mil.
Net Income was NT$-5.00 Mil.
Gross Profit was NT$0.00 Mil.
Cash Flow from Operations was NT$-6.59 Mil.
Total Receivables was NT$16.34 Mil.
Revenue was NT$98.06 Mil.
Gross Profit was NT$73.78 Mil.
Total Current Assets was NT$263.82 Mil.
Total Assets was NT$330.15 Mil.
Property, Plant and Equipment(Net PPE) was NT$65.40 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$6.52 Mil.
Selling, General, & Admin. Expense(SGA) was NT$48.40 Mil.
Total Current Liabilities was NT$29.29 Mil.
Long-Term Debt & Capital Lease Obligation was NT$1.74 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(16.611 / 83.043) / (16.338 / 98.058)
=0.200029 / 0.166616
=1.2005

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(73.781 / 98.058) / (58.551 / 83.043)
=0.752422 / 0.705068
=1.0672

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (249.991 + 65.814) / 320.253) / (1 - (263.819 + 65.402) / 330.148)
=0.013889 / 0.002808
=4.9462

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=83.043 / 98.058
=0.8469

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(6.524 / (6.524 + 65.402)) / (8.688 / (8.688 + 65.814))
=0.090704 / 0.116614
=0.7778

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(56.84 / 83.043) / (48.397 / 98.058)
=0.684465 / 0.493555
=1.3868

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.07 + 26.076) / 320.253) / ((1.743 + 29.294) / 330.148)
=0.081642 / 0.094009
=0.8684

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-5.004 - 0 - -6.588) / 320.253
=0.004946

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Horien Biochemical Technology Co has a M-score of -0.83 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -0.83 mean?
Horien Biochemical Technology Co (ROCO:7814) has a Beneish M-Score of -0.83 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Horien Biochemical Technology Co and its competitors. According to the industry distribution chart, Horien Biochemical Technology Co ranks #659 out of 829 companies in the Biotechnology industry, placing it in the top 79.5%.
Is Horien Biochemical Technology Co's Beneish M-Score too high?
Horien Biochemical Technology Co's current Beneish M-Score is -0.83. Based on the distribution chart, Horien Biochemical Technology Co ranks #659 out of 829 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Horien Biochemical Technology Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Horien Biochemical Technology Co's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Horien Biochemical Technology Co ranks #659 out of 829 companies for Beneish M-Score. This places Horien Biochemical Technology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Horien Biochemical Technology Co and its competitors. Horien Biochemical Technology Co's current Beneish M-Score is -0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Horien Biochemical Technology Co stock overvalued right now?
Horien Biochemical Technology Co (ROCO:7814) has a current Beneish M-Score of -0.83. The current Beneish M-Score is -0.83. Horien Biochemical Technology Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Horien Biochemical Technology Co (ROCO:7814), the current Beneish M-Score is -0.83 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Horien Biochemical Technology Co Business Description

Address Gongyecyu 38th Road, 7F-5 & 6, NO. 210, Situn District, Siehe Village, Taichung, TWN, 40768
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
21GF Score

Get the complete analysis for ROCO:7814

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.65
Price